Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine in Healthy Smokers
NCT00785460Phase 3Completed
- Sponsor
- Ruhr University Bochum
- Start
- Jan 2008
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of benfotiamine in vascular dysfunction (2 arms), sponsored by Ruhr University Bochum. Primary endpoint: Flow Mediated Dilatation at 3 days. Started Jan 2008; status: completed.
02
Drugs
benfotiamine
03
Conditions
vascular dysfunction
Beyond the preview
Go deeper on NCT00785460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785460.